| Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. | |
| | |
MedLine Citation:
|
PMID: 23280226 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
IMPORTANCE: Increases in fructose consumption have paralleled the increasing prevalence of obesity, and high-fructose diets are thought to promote weight gain and insulin resistance. Fructose ingestion produces smaller increases in circulating satiety hormones compared with glucose ingestion, and central administration of fructose provokes feeding in rodents, whereas centrally administered glucose promotes satiety. OBJECTIVE: To study neurophysiological factors that might underlie associations between fructose consumption and weight gain. DESIGN, SETTING, AND PARTICIPANTS: Twenty healthy adult volunteers underwent 2 magnetic resonance imaging sessions at Yale University in conjunction with fructose or glucose drink ingestion in a blinded, random-order, crossover design. MAIN OUTCOME MEASURES: Relative changes in hypothalamic regional cerebral blood flow (CBF) after glucose or fructose ingestion. Secondary outcomes included whole-brain analyses to explore regional CBF changes, functional connectivity analysis to investigate correlations between the hypothalamus and other brain region responses, and hormone responses to fructose and glucose ingestion. RESULTS: There was a significantly greater reduction in hypothalamic CBF after glucose vs fructose ingestion (-5.45 vs 2.84 mL/g per minute, respectively; mean difference, 8.3 mL/g per minute [95% CI of mean difference, 1.87-14.70]; P = .01). Glucose ingestion (compared with baseline) increased functional connectivity between the hypothalamus and the thalamus and striatum. Fructose increased connectivity between the hypothalamus and thalamus but not the striatum. Regional CBF within the hypothalamus, thalamus, insula, anterior cingulate, and striatum (appetite and reward regions) was reduced after glucose ingestion compared with baseline (P < .05 significance threshold, family-wise error [FWE] whole-brain corrected). In contrast, fructose reduced regional CBF in the thalamus, hippocampus, posterior cingulate cortex, fusiform, and visual cortex (P < .05 significance threshold, FWE whole-brain corrected). In whole-brain voxel-level analyses, there were no significant differences between direct comparisons of fructose vs glucose sessions following correction for multiple comparisons. Fructose vs glucose ingestion resulted in lower peak levels of serum glucose (mean difference, 41.0 mg/dL [95% CI, 27.7-54.5]; P < .001), insulin (mean difference, 49.6 μU/mL [95% CI, 38.2-61.1]; P < .001), and glucagon-like polypeptide 1 (mean difference, 2.1 pmol/L [95% CI, 0.9-3.2]; P = .01). CONCLUSION AND RELEVANCE: In a series of exploratory analyses, consumption of fructose compared with glucose resulted in a distinct pattern of regional CBF and a smaller increase in systemic glucose, insulin, and glucagon-like polypeptide 1 levels. |
| | |
Authors:
|
Kathleen A Page; Owen Chan; Jagriti Arora; Renata Belfort-Deaguiar; James Dzuira; Brian Roehmholdt; Gary W Cline; Sarita Naik; Rajita Sinha; R Todd Constable; Robert S Sherwin |
Related Documents
:
|
22920816 - A fluorescent responsive hybrid nanogel for closed-loop control of glucose. 17098486 - Capillary electrophoretic assay for nitrate levels in the vitreous of proliferative dia... 21604006 - Effects of diabetes mellitus on the rat liver during the postmenopausal period. 20636486 - Combination therapy in diabetic macular oedema and retinal vein occlusion - past and pr... 22876556 - Simultaneous onset and similar course of type 1 diabetes mellitus in monozygotic twins ... 19664906 - Roles for cathepsins s, l, and b in insulitis and diabetes in the nod mouse. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
Journal Detail:
|
Title: JAMA : the journal of the American Medical Association Volume: 309 ISSN: 1538-3598 ISO Abbreviation: JAMA Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-01-02 Completed Date: 2013-01-03 Revised Date: 2013-05-06 |
Medline Journal Info:
|
Nlm Unique ID: 7501160 Medline TA: JAMA Country: United States |
Other Details:
|
Languages: eng Pagination: 63-70 Citation Subset: AIM; IM |
Affiliation:
|
Section of Endocrinology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520-8020, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Animals Appetite / drug effects, physiology Beverages Blood-Brain Barrier Brain / blood supply*, drug effects* Cross-Over Studies Female Fructose / administration & dosage, pharmacokinetics, pharmacology* Glucagon-Like Peptide 1 / drug effects, metabolism Glucose / administration & dosage, metabolism, pharmacology* Humans Hunger / drug effects, physiology Hypothalamus / blood supply, drug effects Insulin / metabolism Magnetic Resonance Imaging Male Rats Regional Blood Flow / drug effects* Reward Single-Blind Method |
| Grant Support | |
ID/Acronym/Agency:
|
DK 20495/DK/NIDDK NIH HHS; P30 DK 45735/DK/NIDDK NIH HHS; T32 DK07058/DK/NIDDK NIH HHS; UL1 RR024139/RR/NCRR NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Insulin; 30237-26-4/Fructose; 50-99-7/Glucose; 89750-14-1/Glucagon-Like Peptide 1 |
| Comments/Corrections | |
Comment In:
|
JAMA. 2013 May 1;309(17):1768-9
[PMID:
23632710
]
JAMA. 2013 Jan 2;309(1):85-6 [PMID: 23280229 ] JAMA. 2013 May 1;309(17):1768 [PMID: 23632709 ] JAMA. 2013 May 1;309(17):1769 [PMID: 23632711 ] |
Erratum In:
|
JAMA. 2013 May 1;309(17):1773 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinic...
Next Document: Association of all-cause mortality with overweight and obesity using standard body mass index catego...